Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry.

Davis, Joanne; Sharma, Sanjeev; Shumway, Richard; Perry, David; Bydder, Sean; Simpson, C Kelley; D'Ambrosio, David

Davis, Joanne; Sharma, Sanjeev; Shumway, Richard; Perry, David; Bydder, Sean; Simpson, C Kelley; D'Ambrosio, David.

Affiliation

Davis J; Clinical Programs, The Radiosurgery Society.
Sharma S; Department of Radiation Oncology, St. Mary's Medical Center.
Shumway R; Department of Radiation Oncology, Saint Francis Hospital and Medical Center.
Perry D; Radiation Oncology, Medstar Franklin Square Medical Center, Baltimore, MD.
Bydder S; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Australia.
Simpson CK; Radiation Oncology, Colorado CyberKnife, Lafayette, CO.
D'Ambrosio D; Radiation Oncology, Community Medical Center-Barnabas Health ; NJ Cyberknife, Community Medical Center-Barnabas Health.

Cureus ; 7(12): e395, 2015 Dec 04.

Article in En | MEDLINE | ID: mdl-26798571

Key words

aging; disease-free survival; genitourinary malignancies; prostate cancer; prostate-specific antigen; psa; registry; sbrt; stereotactic body radiotherapy

Fulltext

XML

PubMed Links

Search on Google